Search clinical trials for: EMPAGLIFLOZIN PLACEBO
Total 54292 results
-
Damanhour UniversityMenoufia UniversityUnknownCardiomyopathies | Diabete Type 2 | Heart Failure With Reduced Ejection Fraction (HFrEF)
-
Shahid Beheshti University of Medical SciencesRecruitingKidney Transplant; ComplicationsIran, Islamic Republic of
-
Ananda Basu, MDNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); DexCom... and other collaboratorsCompletedType 1 DiabetesUnited States
-
Boehringer IngelheimEli Lilly and CompanyCompletedObesity | Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1Canada
-
University at BuffaloKaleida HealthCompletedAn Investigation Into The Anti-hypertensive And Potential Anti-inflammatory Actions Of DapagliflozinType 2 DiabetesUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Croatia, Italy, Poland, Russian Federation, Spain, Greece, Serbia, Thailand, Brazil, Hungary, Argentina
-
China National Center for Cardiovascular DiseasesRecruitingHypertrophic Cardiomyopathy | Heart Failure With Preserved Ejection FractionChina
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of Sao PauloCompletedDiabetes Mellitus, Type 2 | Coronary Heart Disease | Arrythmia, CardiacBrazil
-
Boehringer IngelheimEli Lilly and CompanyActive, not recruiting
-
Vanderbilt University Medical CenterCompletedObesity | Pre-diabetesUnited States
-
Stanford UniversityCompletedLiver Cirrhosis | Cirrhosis | Ascites | Ascites Hepatic | Sodium-Glucose Transporter 2 InhibitorsUnited States
-
Zhijun SunEnrolling by invitationHeart Failure | Heart Failure With Preserved Ejection FractionChina
-
Kobe UniversityBoehringer IngelheimActive, not recruitingInsulin Resistance - Type A | Insulin Resistance - Type B | Lipoatrophic Diabetes Mellitus | Insulin Resistance SyndromeJapan
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusUnited Kingdom
-
Ain Shams UniversityNot yet recruiting
-
Alexandria UniversityRecruitingHeart Failure With Reduced Ejection FractionEgypt
-
Aristotle University Of ThessalonikiUnknownHypertension | Type II DiabetesGreece
-
The George InstituteUniversity Medical Center Groningen; Australian and New Zealand Intensive Care...RecruitingAcute Kidney InjuryAustralia
-
AstraZenecaAstraZeneca, Bristol-Myers SquibbCompletedType 2 DiabetesChina, Korea, Republic of, Taiwan, India
-
Amsterdam UMC, location VUmcCompleted
-
University of LeicesterAstraZeneca; Royal Surrey County Hospital NHS Foundation TrustCompletedThe Effect of a SGLT2 Inhibitor on Glucose Flux, Lipolysis and Exercise in Type 2 Diabetes (SINGLED)Type 2 DiabetesUnited Kingdom
-
State University of New York at BuffaloJuvenile Diabetes Research Foundation; University of GlasgowRecruiting
-
Fundación Pública Andaluza para la Investigación...Unknown
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesAustralia, United States, Canada, Mexico, Puerto Rico, Germany, Hungary, Ireland, Poland, Romania, Denmark, Czech Republic, India, Colombia, Finland, United Kingdom
-
Ann & Robert H Lurie Children's Hospital of ChicagoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Not yet recruitingChronic Kidney Diseases | Pediatric Kidney DiseaseUnited States
-
Amsterdam UMC, location VUmcRecruitingIdiopathic Pulmonary Arterial HypertensionNetherlands
-
University of Texas Southwestern Medical CenterBoehringer IngelheimCompletedDiabetes Mellitus | Heart Failure, Diastolic | Heart Failure With Preserved Ejection FractionUnited States
-
Zhijun SunEnrolling by invitationHeart Failure | Heart Failure With Preserved Ejection Fraction | Heart Failure With Mid Range Ejection FractionChina
-
Isfahan University of Medical SciencesCompletedDiabetes MellitusIran, Islamic Republic of
-
Ain Shams UniversityCompletedPharmacokinetics | PharmacogenomicEgypt
-
National Institute on Aging (NIA)CompletedPhysiological Effects of Drugs | Hypoglycemic Agents | Empaglifozin | Sodium-Glucose Transporter 2 InhibitorsUnited States
-
Mario Negri Institute for Pharmacological ResearchBoehringer IngelheimWithdrawnObesity | Non-diabetic Chronic Kidney Disease
-
Yaounde Central HospitalCompleted
-
Boehringer IngelheimCompleted
-
McGill University Health Centre/Research Institute...Diabetes CanadaRecruiting
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Japan
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2China
-
Boehringer IngelheimEli Lilly and CompanyCompletedMyocardial InfarctionUnited States, Spain, Australia, Denmark, Netherlands, Canada, China, Germany, Korea, Republic of, Israel, Hungary, Japan, Argentina, France, Romania, Russian Federation, Serbia, Ukraine, Poland, India, Brazil, Bulgaria
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 1United States, United Kingdom, Canada, Italy, Hungary, Spain, Sweden, Australia, Netherlands, France, Czechia, Finland, Germany, Greece, Ireland, Latvia, Mexico, New Zealand, Norway, Poland, Portugal, Romania, Russian Federation, South...
-
University Hospital TuebingenWithdrawn
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Singapore General HospitalDuke-NUS Graduate Medical SchoolTerminatedDiabetic NephropathiesSingapore
-
AstraZenecaCompletedType 1 Diabetes MellitusJapan
-
AstraZenecaBristol-Myers SquibbCompletedStudy of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 DiabetesType 2 Diabetes MellitusKorea, Republic of, United States, Mexico, India, Puerto Rico, Russian Federation
-
Oman Ministry of HealthNot yet recruitingObesity | Weight Loss | Effect of Drug | Dapagliflozin Adverse Reaction
-
University of EdinburghAstraZeneca; NHS LothianRecruiting
-
AstraZenecaAstraZeneca, Bristol-Myers SquibbCompletedType 2 DiabetesChina, Korea, Republic of, India
-
University Health Network, TorontoNot yet recruitingEnd Stage Kidney Disease | Kidney Dysfunction | Peritoneal Dialysis Complication | Sodium-glucose Co-transporter-2 Inhibitors | Residual Kidney FunctionCanada